Quantcast

Latest Bcl-2 Stories

2015-05-11 08:30:41

17 abstracts include data from: NORTH CHICAGO, Ill., May 11, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced 17 abstracts from studies of the company's oncology pipeline are being presented

2015-04-14 16:28:43

DUBLIN, April 14, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/c2rl8f/oncogene) has announced the addition of the "Oncogene Inhibitors

2015-01-07 12:26:43

- First Patient Dosed in the "Wolverine" Phase II Trial Evaluating ProNAi's BCL2 Targeting DNAi(®) Therapeutic PNT2258 - VANCOUVER, BC and PLYMOUTH, MI, Jan.

2014-06-09 14:34:42

Follicular lymphoma, a B cell lymphoma, is an incurable form of non-Hodgkin lymphoma that is diagnosed each year in 120,000 people worldwide.

2014-04-23 08:31:41

- Investigators to Present Clinical Trial Findings Evaluating Compounds in Multiple Tumor Types NORTH CHICAGO, Ill., April 23, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that

2014-01-08 17:07:21

Walter and Eliza Hall Institute researchers have discovered a promising strategy for treating cancers that are caused by one of the most common cancer-causing changes in cells.

2013-07-09 11:33:27

Pancreatic cancer is one of the most deadly and intractable forms of cancer, with a 5-year survival rate of only 6%.

New Compound BH3 Mimetics Future Of Breast Cancer Treatment
2013-07-09 09:40:18

Scientists from Melbourne, Australia recently discovered compounds known as BH3-mimetics currently being researched to treat leukemia may also be effective in treating breast cancer.


Word of the Day
begunk
  • To befool; deceive; balk; jilt.
  • An illusion; a trick; a cheat.
The word 'begunk' may come from a nasalised variant of Scots begeck ("to deceive, disappoint"), equivalent to be- +‎ geck.